Maryland's Hospital Utilization Drops Significantly Under Global Budgets
A recent study highlights a notable decline in hospital utilization in Maryland, showing an 11 percentage point decrease compared to other states from 2013 to 2023.
Examining Two Decades of US Spending on Mental Health and Substance Use Treatment
A recent analysis highlights the trends in national spending on mental health and substance use disorder treatment from 2000 to 2021, reflecting case growth over the years.
Revolution Medicines' Daraxonrasib Shows Promise in Pancreatic Cancer Treatment
The pancreatic cancer drug Daraxonrasib from Revolution Medicines is reportedly achieving remarkable results, with some patients experiencing doubled survival times.
Trump's Push for Psychedelic Treatment Access and Reevaluation
In a recent directive, Trump has called on federal agencies to expedite access to psychedelic treatments and reconsider their classification as controlled substances.
Bridging the Gap: MAHA and Public Health in Dialogue
The podcast 'Why Should I Trust You?' emphasizes the need for communication between MAHA and public health, highlighting the stakes involved.
Mixed Feelings Surround Trump's CDC Appointment Amid RFK Jr. Concerns
While there is a sense of optimism regarding Trump's choice for the CDC, employees express a cautious outlook, especially concerning RFK Jr.'s involvement.
Analyzing Trends in Employer-Sponsored Health Insurance Coverage
A recent analysis reveals trends in employer-based health insurance, affecting 165.6 million individuals under 65 years old as of March 2025.
Truist Revises Outlook for Community Health Systems Amid Sector Changes
In a recent update, Truist has adjusted its outlook for Community Health Systems, Inc. as part of a broader review of the healthcare sector.
Understanding Vaccine Trust: A Closer Look at Recent Polls
Recent headlines may suggest a growing skepticism towards vaccines among Americans, but a new poll indicates that this perception may not reflect reality.
The Vulnerability of Health Care to AI-Driven Cyber Threats
As cyberattacks on health care systems escalate, the potential for patient harm grows. Andrea Downing highlights the urgent need for improved defenses against these threats.
Current Trends in MAHA: Breakthroughs and Challenges
Recent updates on MAHA highlight a significant breakthrough in Duchenne muscular dystrophy, alongside ongoing challenges in cancer treatment and other health developments.
Reviving Hope: A Mother's Fight for Neuromuscular Drug Class
A mother's determination has reignited interest in a neglected class of drugs, potentially benefiting her son and many others with neuromuscular disorders.
Molecular 'leash' measures force-sensing protein activation at about 15 piconewtons
Strategic angle: Researchers at NUS develop a molecular tool to study Piezo1 protein activation under mechanical force.
Who got the meat? What 10,000 years of European bones suggest about diet inequality
Strategic angle: Access to nutritious food has been historically unequal, with meat being a coveted resource in pre-industrial Europe.
‘Arbitrary and capricious’: 130 Hospitals sue HHS over billions in Medicare payouts
Strategic angle: What it means for your health care
Trump Budget’s ‘America First’ Drug Policy Proposals
Strategic angle: New ideas to bring drug manufacturing to the U.S. are included in Trump's 2027 budget proposal.
Many cancer patients don’t get genomic tests to guide treatment, study finds
Strategic angle: Even as therapies improve, a startling number of cancer patients are not getting genomic tests that could improve their chance of survival.
FDA Seeks to Strengthen Domestic Drug Manufacturing Through New Proposals
In a move to enhance local drug production, the FDA has proposed new policies as part of the president's budget, aiming to support domestic drug development.
Capping Insulin Costs at $35 May Improve Treatment Adherence for Type 2 Diabetes
A recent study suggests that limiting insulin prices to $35 per month could enhance adherence to treatment among individuals with type 2 diabetes, highlighting the potential impact of cost on health outcomes.
Opinion: STAT+: Former Geisinger CEO: U.S. health systems must replace huge numbers of people with AI
Strategic angle: “Health care will become autonomous because the survival of health systems depends upon it,” writes former Geisinger CEO Glenn Steele.